- Legend Biotech USA, Inc. (Piscataway, NJ)
- …chimeric antigen receptor T-cell and natural killer (NK) cell-based immunotherapy .Legend Biotech entered into a global collaboration agreement with Janssen, ... of both companies to advance the promise of an immunotherapy in the treatment of multiple myeloma.Legend Biotech is...groundbreaking treatments and have a strong background in cellular immunotherapy , this role is for you. The successful candidate… more
- Legend Biotech USA, Inc. (Piscataway, NJ)
- …chimeric antigen receptor T-cell and natural killer (NK) cell-based immunotherapy .Legend Biotech entered into a global collaboration agreement with Janssen, ... of both companies to advance the promise of an immunotherapy in the treatment of multiple myeloma.Legend Biotech is...groundbreaking treatments and have a strong background in cellular immunotherapy , this role is for you. The successful candidate… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …chimeric antigen receptor T-cell and natural killer (NK) cell-based immunotherapy .Legend Biotech entered into a global collaboration agreement with Janssen, ... strengths and expertise of both companies to advance the promise of an immunotherapy in the treatment of multiple myeloma.Legend Biotech is seeking QA Document… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …chimeric antigen receptor T-cell and natural killer (NK) cell-based immunotherapy .Legend Biotech entered into a global collaboration agreement with Janssen, ... strengths and expertise of both companies to advance the promise of an immunotherapy in the treatment of multiple myeloma.Legend Biotech is seeking an Asset… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …chimeric antigen receptor T-cell and natural killer (NK) cell-based immunotherapy .Legend Biotech entered into a global collaboration agreement with Janssen, ... strengths and expertise of both companies to advance the promise of an immunotherapy in the treatment of multiple myeloma.Legend Biotech is seeking QC Microbiology… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …chimeric antigen receptor T-cell and natural killer (NK) cell-based immunotherapy .Legend Biotech entered into a global collaboration agreement with Janssen, ... strengths and expertise of both companies to advance the promise of an immunotherapy in the treatment of multiple myeloma.Legend Biotech is seeking QC Microbiology… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …chimeric antigen receptor T-cell and natural killer (NK) cell-based immunotherapy .Legend Biotech entered into a global collaboration agreement with Janssen, ... of both companies to advance the promise of an immunotherapy in the treatment of multiple myeloma.Legend Biotech is...of two companies to advance the promise of an immunotherapy CAR T platform and investigational treatment.Role OverviewThe QC… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …chimeric antigen receptor T-cell and natural killer (NK) cell-based immunotherapy .Legend Biotech entered into a global collaboration agreement with Janssen, ... strengths and expertise of both companies to advance the promise of an immunotherapy in the treatment of multiple myeloma.Legend Biotech is seeking QA Batch… more
- Aequor (South San Francisco, CA)
- …computational biology and/or cancer immunology. He/She will support personalized cancer immunotherapy research. The successful candidate will have a proven track ... data infrastructure for research projects related to individualized cancer immunotherapy Collaborate with computational biologists, AI scientists and engineers… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …chimeric antigen receptor T-cell and natural killer (NK) cell-based immunotherapy .Legend Biotech entered into a global collaboration agreement with Janssen, ... the strengths and expertise of both companies to advance the promise of an immunotherapy in the treatment of multiple myeloma.Legend Biotech is seeking a QA Shop… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …chimeric antigen receptor T-cell and natural killer (NK) cell-based immunotherapy .Legend Biotech entered into a global collaboration agreement with Janssen, ... and expertise of both companies to advance the promise of an immunotherapy in the treatment of multiple myeloma.Legend Biotech is seeking Operations Manager… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …chimeric antigen receptor T-cell and natural killer (NK) cell-based immunotherapy .Legend Biotech entered into a global collaboration agreement with Janssen, ... strengths and expertise of both companies to advance the promise of an immunotherapy in the treatment of multiple myeloma.Legend Biotech is seeking Risk Assessment… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …chimeric antigen receptor T-cell and natural killer (NK) cell-based immunotherapy .Legend Biotech entered into a global collaboration agreement with Janssen, ... strengths and expertise of both companies to advance the promise of an immunotherapy in the treatment of multiple myeloma.Legend Biotech is seeking Quality Project… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …chimeric antigen receptor T-cell and natural killer (NK) cell-based immunotherapy .Legend Biotech entered into a global collaboration agreement with Janssen, ... strengths and expertise of both companies to advance the promise of an immunotherapy in the treatment of multiple myeloma.Legend Biotech is seeking Planner, Batch… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …chimeric antigen receptor T-cell and natural killer (NK) cell-based immunotherapy .Legend Biotech entered into a global collaboration agreement with Janssen, ... strengths and expertise of both companies to advance the promise of an immunotherapy in the treatment of multiple myeloma.Legend Biotech is seeking a MES Engineer… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …chimeric antigen receptor T-cell and natural killer (NK) cell-based immunotherapy .Legend Biotech entered into a global collaboration agreement with Janssen, ... and expertise of both companies to advance the promise of an immunotherapy in the treatment of multiple myeloma.Legend Biotech is seeking Environment, Health… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …chimeric antigen receptor T-cell and natural killer (NK) cell-based immunotherapy .Legend Biotech entered into a global collaboration agreement with Janssen, ... strengths and expertise of both companies to advance the promise of an immunotherapy in the treatment of multiple myeloma.Legend Biotech is seeking an Investigator I… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …chimeric antigen receptor T-cell and natural killer (NK) cell-based immunotherapy .Legend Biotech entered into a global collaboration agreement with Janssen, ... strengths and expertise of both companies to advance the promise of an immunotherapy in the treatment of multiple myeloma.Legend Biotech is seeking HR Generalist as… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …chimeric antigen receptor T-cell and natural killer (NK) cell-based immunotherapy .Legend Biotech entered into a global collaboration agreement with Janssen, ... strengths and expertise of both companies to advance the promise of an immunotherapy in the treatment of multiple myeloma.Legend Biotech is seeking a Vice President… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …chimeric antigen receptor T-cell and natural killer (NK) cell-based immunotherapy .Legend Biotech entered into a global collaboration agreement with Janssen, ... strengths and expertise of both companies to advance the promise of an immunotherapy in the treatment of multiple myeloma.Legend Biotech is seeking an Operations… more